InnoCan Pharma Corporation (CSE:INNO)
1.790
-0.050 (-2.72%)
Nov 19, 2026, 4:44 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.